Nuvilex Associate Expands Ownership of Patents to Include Production of Therapeutic Antibodies
Published: Dec 20, 2011
SILVER SPRING, Md.--(BUSINESS WIRE)--Nuvilex, Inc. (OTCQB:NVLX) through their associate, Singapore based biotechnology group SG Austria, announced the expanded ownership of patents controlling production of therapeutic antibodies. This will lead to future expanded revenue potential. This particular patent family covers encapsulation of therapeutic antibodies made to aid the immune system fight disease.